A malic enzyme inhibitor
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Malic Enzyme Inhibitor ME1

Item No. 44383

Technical Information
Formal Name
3-[4-(4-hydroxyphenyl)-1-piperazinyl]-1-phenyl-2,5-pyrrolidinedione
CAS Number
522649-59-8
Molecular Formula
C20H21N3O3
Formula Weight
Purity
≥98%
A solid
DMSO: Soluble: ≥ 10 mg/ml
SMILES
OC1=CC=C(N2CCN(C(C(N3C4=CC=CC=C4)=O)CC3=O)CC2)C=C1
InChi Code
InChI=1S/C20H21N3O3/c24-17-8-6-15(7-9-17)21-10-12-22(13-11-21)18-14-19(25)23(20(18)26)16-4-2-1-3-5-16/h1-9,18,24H,10-14H2
InChi Key
JJFJQFJFFVLMCX-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Malic enzyme inhibitor ME1 is an inhibitor of malic enzyme (ME; IC50s = 0.22, 0.2, and 0.15 µM for ME1, ME2, and ME3, respectively).1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sheth, G., Shah, S.R., Sengupta, P., et alIn the quest for potent and selective malic enzyme 3 inhibitors for the treatment of pancreatic ductal adenocarcinoma. ACS Med. Chem. Lett. 14(1), 41-50 (2022).